Filtered By:
Countries: India Health

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 6839 results found since Jan 2013.

Partial segmental thrombosis of the corpus cavernosum following Russell's viper bite
In conclusion, this case report exemplifies the development of a rare segmental thrombosis in corpus cavernosum and how the medical, scientific, and general community can benefit from documenting clinical manifestations, medically relevant insights into patient care and the management of underreported complications.PMID:37683700 | DOI:10.1016/j.toxicon.2023.107284
Source: Toxicon - September 8, 2023 Category: Toxicology Authors: Subramanian Senthilkumaran Sasikumar Sampath Stephen W Miller Jos é R Almeida Jarred Williams Harry F Williams Ponniah Thirumalaikolundusubramanian Ketan Patel Sakthivel Vaiyapuri Source Type: research

“Unusual Presentation of Epitheloid Dermatofibroma- Rare Case Report”
AbstractDermatofibroma is a commonly occurring cutaneous entity usually centered within the skin ’s dermis. Dermatofibromas are referred to as benign fibrous histiocytomas of the skin, superficial/cutaneous benign fibrous histiocytomas, or common fibrous histiocytoma. These mesenchymal cell lesions of the dermis clinically are firm subcutaneous nodules that occur on the extremities in the vas t majority of cases and may or may not be associated with overlying skin changes. A 20 years old male presented to ENT OPD, at a private hospital, with complaints of a huge mass over right side of face since 15 years, which was s...
Source: Indian Journal of Otolaryngology and Head and Neck Surgery - September 8, 2023 Category: ENT & OMF Source Type: research

Immunogenicity and safety of Havisure < sup > TM < /sup > vaccine developed by Human Biologicals Institute in healthy subjects of 12  months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
CONCLUSION: The study results indicate that the Havisure™ vaccine is immunogenic and safe when administered to healthy subjects of 12 months to 49 years of age, and is non-inferior to Havrix® Vaccine.PMID:37661535 | DOI:10.1016/j.vaccine.2023.08.084
Source: Vaccine - September 4, 2023 Category: Allergy & Immunology Authors: Sai Krishna Susarla Madhu Gupta Kheya Ghosh Uttam Sonali Palkar Ashish Ramachandra Dhongade K Siva Ram Prasad Vasudev Rajapantula M D Ravi N Pradeep M Satish B C Rajashakar G Sandhya L Rajendra Devi Prasad Sahoo Anand Kumar Kanakasapapathy Source Type: research

Standing the test of time: total aortic remodeling 13  years after TEVAR for acute type B aortic dissection
AbstractLong-term outcome after thoracic endovascular aortic repair (TEVAR) of acute type B aortic dissection (aTBAD) is still underreported in current literature. This case report shows persistence of aortic remodeling without secondary complication or need of reintervention 13  years after TEVAR. A 45-year-old woman was referred to the emergency room with aTBAD. Due to early diameter progression in combination with therapy-refractory pain and uncontrolled hypertension, TEVAR was performed. Hereafter, the patient showed complete remodeling of the descending thoracic aorta without persistent false lumen perfusion in this ...
Source: Indian Journal of Thoracic and Cardiovascular Surgery - September 4, 2023 Category: Cardiovascular & Thoracic Surgery Source Type: research

Musculoskeletal Pain and Injury in Indian Classical Dancers: A Systematic Review
Med Probl Perform Art. 2023 Sep;38(3):164-171. doi: 10.21091/mppa.2023.3020.ABSTRACTThe majority of current research on dance injuries has been on ballet, leaving a void in recent data on musculoskeletal injuries in Indian classical [IC] dance. The prevalence of injuries among IC dancers remains unclear, stressing the importance of injury epidemiology research for improved diagnosis, treatment, prevention, and injury burden reduction. Through a thorough examination of published literature, this study sought to critically evaluate existing research on the epidemiology of musculoskeletal pain and injury in IC dancers. Using ...
Source: Medical Problems of Performing Artists - September 2, 2023 Category: Sports Medicine Authors: Akilesh Anand Prakash D Subaskaran Vinitha Akilesh Source Type: research

Immunogenicity and safety of Mebella ™ vaccine developed by Human Biologicals Institute in a Phase II/III, randomized, multicentric, non-inferiority study
CONCLUSION: It was concluded from the study results that the test vaccine, Mebella™, was immunogenic and well tolerated and was non-inferior to the comparator vaccine, MR-VAC®, when administered to healthy subjects of 9 months to 49 years of age. Clinical Trial Registry of India Identifier: CTRI/2020/07/026930.PMID:37659893 | DOI:10.1016/j.vaccine.2023.08.065
Source: Vaccine - September 2, 2023 Category: Allergy & Immunology Authors: Sai Krishna Susarla Rahul Jahagirdar Kheya Ghosh Uttam S Srikanth Bhatt S Prashanth Vasudev Rajapantula M Satish B C Rajashakar G Sandhya L Rajendra Devi Prasad Sahoo Anand Kumar Kanakasapapathy Source Type: research

Musculoskeletal Pain and Injury in Indian Classical Dancers: A Systematic Review
Med Probl Perform Art. 2023 Sep;38(3):164-171. doi: 10.21091/mppa.2023.3020.ABSTRACTThe majority of current research on dance injuries has been on ballet, leaving a void in recent data on musculoskeletal injuries in Indian classical [IC] dance. The prevalence of injuries among IC dancers remains unclear, stressing the importance of injury epidemiology research for improved diagnosis, treatment, prevention, and injury burden reduction. Through a thorough examination of published literature, this study sought to critically evaluate existing research on the epidemiology of musculoskeletal pain and injury in IC dancers. Using ...
Source: Medical Problems of Performing Artists - September 2, 2023 Category: Sports Medicine Authors: Akilesh Anand Prakash D Subaskaran Vinitha Akilesh Source Type: research